scholarly article | Q13442814 |
P50 | author | J M Kahlenberg | Q73930082 |
Victoria Holden | Q82737309 | ||
P2093 | author name string | Mariana J Kaplan | |
Carolyne K Smith | |||
Emily M Myers | |||
Alyssa M Cates | |||
P2860 | cites work | Protective Role of Interleukin-10 in Atherosclerosis | Q58150380 |
Serum cytokine profile in patients with active lupus nephritis | Q63431624 | ||
Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients | Q73028013 | ||
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 | ||
Elevated circulating CD4+ ICOS+ Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus | Q84072421 | ||
Type I and III interferons enhance IL-10R expression on human monocytes and macrophages, resulting in IL-10-mediated suppression of TLR-induced IL-12 | Q84347520 | ||
Junctional adhesion molecule-C is a soluble mediator of angiogenesis | Q24337026 | ||
Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium | Q24629800 | ||
The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction | Q30497355 | ||
Comparative effects of n-3, n-6 and n-9 unsaturated fatty acid-rich diet consumption on lupus nephritis, autoantibody production and CD4+ T cell-related gene responses in the autoimmune NZBWF1 mouse | Q33778956 | ||
IL-18 induces profibrotic renal tubular cell injury via STAT3 activation | Q33816800 | ||
Down-regulated NOD2 by immunosuppressants in peripheral blood cells in patients with SLE reduces the muramyl dipeptide-induced IL-10 production. | Q34008997 | ||
An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage | Q34055844 | ||
IL-10 gene polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis | Q34920423 | ||
Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells | Q35152132 | ||
Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus | Q35566819 | ||
Interferon-alpha in systemic lupus erythematosus | Q35864686 | ||
Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis | Q36059617 | ||
Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis | Q36139902 | ||
The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development | Q37734546 | ||
Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair | Q40417766 | ||
Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-alpha involves activation of the MKK6/p38MAPK/MK2 cascade | Q42508566 | ||
Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease | Q43664648 | ||
Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients. | Q47426474 | ||
IL-10 fails to inhibit the production of IL-18 in response to inflammatory stimuli | Q47999845 | ||
Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome. | Q48823158 | ||
Decreased circulating endothelial progenitor cells as an early risk factor of subclinical atherosclerosis in systemic lupus erythematosus. | Q51182420 | ||
Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. | Q51798492 | ||
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation | Q57258441 | ||
Excessive CpG 1668 stimulation triggers IL-10 production by cDC that inhibits IFN-α responses by pDC | Q57339899 | ||
P433 | issue | 6 | |
P921 | main subject | endothelium | Q111140 |
cell differentiation | Q210861 | ||
P304 | page(s) | 1114-1123 | |
P577 | publication date | 2014-11-20 | |
P1433 | published in | Rheumatology | Q7320492 |
P1476 | title | Interleukin 10 hampers endothelial cell differentiation and enhances the effects of interferon α on lupus endothelial cell progenitors | |
P478 | volume | 54 |
Q90455731 | Endothelial Progenitor Cells: New Targets for Therapeutics for Inflammatory Conditions With High Cardiovascular Risk |
Q36373291 | Epidermal injury promotes nephritis flare in lupus-prone mice |
Q47806004 | IFN-α Negatively Regulates the Expression of Endothelial Nitric Oxide Synthase and Nitric Oxide Production: Implications for Systemic Lupus Erythematosus. |
Q40097338 | Immune modulation by curcumin: The role of interleukin-10. |
Q35860085 | Mast Cell Proteases 6 and 7 Stimulate Angiogenesis by Inducing Endothelial Cells to Release Angiogenic Factors |
Q52668758 | Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis. |
Q41087339 | Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction |
Q30993000 | Smoking and Its Association With Morbidity in Systemic Lupus Erythematosus Evaluated by the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index: Preliminary Data and Systematic Review. |
Q38988087 | Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date |
Q37541469 | Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction. |
Q39174289 | Vascular precursor cells in tissue injury repair |
Search more.